CSL.AX Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 07:47):

Stats
Šios dienos apimtis	197 584
Vidutinė apimtis	725 457
Rinkos kapitalizacija	132.38B
EPS	$0 ( 2024-02-13 )
Last Dividend	$1.621 ( 2023-03-09 )
Next Dividend	$0 ( N/A )
P/E	34.94
ATR14	$0.110 (0.04%)

Tūris Koreliacija

Ilgas: -0.04 (neutral)

Trumpas: 0.33 (neutral)

Signal:(61.184) Neutral

CSL Ltd Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

CSL Ltd Koreliacija - Valiuta/Žaliavos

-0.37
( neutral )

-0.51
( weak negative )

0.00
( neutral )

0.25
( neutral )

-0.22
( neutral )

-0.75
( moderate negative )

CSL Ltd Finansinės ataskaitos

Annual	2023
Pajamos:	$19.59B
Bruto pelnas:	$9.47B (48.33 %)
EPS:	$6.92

FY	2023
Pajamos:	$19.59B
Bruto pelnas:	$9.47B (48.33 %)
EPS:	$6.92

FY	2022
Pajamos:	$14.47B
Bruto pelnas:	$7.68B (53.05 %)
EPS:	$6.63

FY	2021
Pajamos:	$10.27B
Bruto pelnas:	$5.80B (56.49 %)
EPS:	$5.22

Financial Reports:

No articles found.

CSL Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$1.758 (N/A)	$0 (N/A)	$1.621 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

CSL Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.26 - Increase likely (45.22%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0167	1994-11-08
Last Dividend	$1.621	2023-03-09
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	59	--
Total Paid Out	$28.07	--
Avg. Dividend % Per Year	0.00%	--
Score	4.48	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.26
Div. Directional Score	9.64	--

Next Divdend (Est)
(2024-06-24)

$0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

4.48

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
CDP.AX	Ex Dividend Junior	2023-06-29	Annually	0.00%
MGR.AX	Ex Dividend Junior	2023-06-29	Semi-Annually	0.00%
TPG.AX	Ex Dividend Knight	2023-09-12	Semi-Annually	0.00%
D2O.AX	Ex Dividend Junior	2023-10-12	Semi-Annually	0.00%
NWH.AX	Ex Dividend Knight	2023-09-21	Semi-Annually	0.00%
ABP.AX	Ex Dividend Junior	2023-06-30	Semi-Annually	0.00%
FPH.AX	Ex Dividend Knight	2023-06-26	Semi-Annually	0.00%
PSQ.AX	Ex Dividend Junior	2023-09-21	Annually	0.00%
AUI.AX	Ex Dividend Knight	2023-08-28	Semi-Annually	0.00%
INA.AX	Ex Dividend Knight	2023-08-25	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.180	1.500	6.41	9.61	[0 - 0.5]
returnOnAssetsTTM	0.0696	1.200	7.68	9.21	[0 - 0.3]
returnOnEquityTTM	0.156	1.500	9.38	10.00	[0.1 - 1]
payoutRatioTTM	0.450	-1.000	5.50	-5.50	[0 - 1]
currentRatioTTM	2.15	0.800	4.25	3.40	[1 - 3]
quickRatioTTM	0.971	0.800	9.00	7.20	[0.8 - 2.5]
cashRatioTTM	0.216	1.500	9.91	10.00	[0.2 - 2]
debtRatioTTM	0.282	-1.500	5.30	-7.95	[0 - 0.6]
interestCoverageTTM	6.97	1.000	8.53	8.53	[3 - 30]
operatingCashFlowPerShareTTM	8.34	2.00	7.22	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.59	2.00	8.21	10.00	[0 - 20]
debtEquityRatioTTM	0.612	-1.500	7.55	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.484	1.000	5.26	5.26	[0.2 - 0.8]
operatingProfitMarginTTM	0.244	1.000	7.12	7.12	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.261	1.000	9.66	9.66	[0.2 - 2]
assetTurnoverTTM	0.388	0.800	-0.748	-0.599	[0.5 - 2]
Total Score				12.02

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	34.66	1.000	6.60	0	[1 - 100]
returnOnEquityTTM	0.156	2.50	9.60	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.59	2.00	8.80	10.00	[0 - 30]
dividendYielPercentageTTM	1.393	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.34	2.00	7.22	10.00	[0 - 30]
payoutRatioTTM	0.450	1.500	5.50	-5.50	[0 - 1]
pegRatioTTM	7.92	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.190	1.000	7.75	0	[0.1 - 0.5]
Total Score				7.26

CSL Ltd

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.